0
13

In This Issue
  |  
The American Journal of Psychiatry

October 01, 2004, Vol. 161, No. 10
Get Alert | RSS  
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

In This Issue
In This Issue
Editorial
The Mosaic of Addiction
CHARLES P. O’BRIEN, M.D., Ph.D.
Reviews and Overviews
Dimensions of Personality Pathology: An Alternative to the Five-Factor Model
Jonathan Shedler, Ph.D.; Drew Westen, Ph.D.
History, Memory, and Profession: A View of American Psychiatry Through APA Presidential Addresses, 1883–2003
Laura D. Hirshbein, M.D., Ph.D.
Article
Altered NMDA Glutamate Receptor Antagonist Response in Individuals With a Family Vulnerability to Alcoholism
Ismene L. Petrakis, M.D.; Diana Limoncelli, B.A.; Ralitza Gueorguieva, Ph.D.; Peter Jatlow, M.D.; Nashaat N. Boutros, M.D.; Louis Trevisan, M.D.; Joel Gelernter, M.D.; John H. Krystal, M.D.
Correlation Between Dopamine D2 Receptors in the Ventral Striatum and Central Processing of Alcohol Cues and Craving
Andreas Heinz, M.D.; Thomas Siessmeier, M.D.; Jana Wrase, Dipl.-Psych.; Derik Hermann, M.D.; Sabine Klein, Ph.D.; Sabine M. Grüsser-Sinopoli, Ph.D.; Herta Flor, Ph.D.; Dieter F. Braus, M.D.; Hans Georg Buchholz, M.S.; Gerhard Gründer, M.D.; Mathias Schreckenberger, M.D.; Michael N. Smolka, M.D.; Frank Rösch, Ph.D.; Karl Mann, M.D.; Peter Bartenstein, M.D.
Alcohol Dependence and Use of Treatment Services Among Women in the Community
Li-Tzy Wu, Sc.D.; Chris L. Ringwalt, Dr.P.H.
Interaction of COMT Val108/158 Met Genotype and Olanzapine Treatment on Prefrontal Cortical Function in Patients With Schizophrenia
Alessandro Bertolino, M.D., Ph.D.; Grazia Caforio, M.D.; Giuseppe Blasi, M.D.; Mariapia De Candia, Ph.D.; Valeria Latorre, M.D.; Vittoria Petruzzella, Ph.D.; Mario Altamura, M.D.; Gaetano Nappi, M.D.; Sergio Papa, M.D.; Joseph H. Callicott, M.D.; Venkata S. Mattay, M.D.; Antonello Bellomo, M.D.; Tommaso Scarabino, M.D.; Daniel R. Weinberger, M.D.; Marcello Nardini, M.D.
Genetic Load on Amygdala Hypofunction During Sadness in Nonaffected Brothers of Schizophrenia Patients
Ute Habel, Ph.D.; Martina Klein, Ph.D.; N. Jon Shah, Ph.D.; Ivan Toni, Ph.D.; Karl Zilles, M.D.; Peter Falkai, M.D.; Frank Schneider, M.D., Ph.D.
High Concordance of Bipolar I Disorder in a Nationwide Sample of Twins
Tuula Kieseppä, M.D.; Timo Partonen, M.D., Ph.D.; Jari Haukka, Ph.D.; Jaakko Kaprio, M.D., Ph.D.; Jouko Lönnqvist, M.D., Ph.D.
Varied Effects of Atypical Neuroleptics on P50 Auditory Gating in Schizophrenia Patients
Lawrence E. Adler; Ann Olincy; Ellen M. Cawthra; Kara A. McRae; Josette G. Harris; Herbert T. Nagamoto; Merilyne C. Waldo; Mei-Hua Hall; Amanda Bowles; Laurie Woodward; Randal G. Ross; Robert Freedman
Reduced Basal Ganglia Volumes After Switching to Olanzapine in Chronically Treated Patients With Schizophrenia
Donna J. Lang, Ph.D.; Lili C. Kopala, M.D., F.R.C.P.C.; Robert A. Vandorpe, M.D., F.R.C.P.C.; Qing Rui, M.B.; Geoffrey N. Smith, Ph.D.; Vina M. Goghari, B.A.; Jocelyne S. Lapointe, M.D., F.R.C.P.C.; William G. Honer, M.D., F.R.C.P.C.
Randomized, Controlled, Double-Blind Multicenter Comparison of the Efficacy and Tolerability of Ziprasidone and Olanzapine in Acutely Ill Inpatients With Schizophrenia or Schizoaffective Disorder
George M. Simpson, M.D.; Ira D. Glick, M.D.; Peter J. Weiden, M.D.; Steven J. Romano, M.D.; Cynthia O. Siu, Ph.D.
Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines
Amanda J. Law, Ph.D.; Cynthia Shannon Weickert, Ph.D.; Thomas M. Hyde, M.D., Ph.D.; Joel E. Kleinman, M.D., Ph.D.; Paul J. Harrison, D.M.(Oxon), F.R.C.Psych.
Neurobiology of Non-REM Sleep in Depression: Further Evidence for Hypofrontality and Thalamic Dysregulation
Anne Germain, Ph.D.; Eric A. Nofzinger, M.D.; David J. Kupfer, M.D.; Daniel J. Buysse, M.D.
Randomized, Placebo-Controlled Trial of Fluoxetine for Acute Treatment of Minor Depressive Disorder
Lewis L. Judd, M.D.; Mark Hyman Rapaport, M.D.; Kimberly A. Yonkers, M.D.; A. John Rush, M.D.; Ellen Frank, Ph.D.; Michael E. Thase, M.D.; David J. Kupfer, M.D.; John M. Plewes, M.D.; Pamela J. Schettler, Ph.D.; Gary Tollefson, M.D., Ph.D.
Six-Year Outcome of Cognitive Behavior Therapy for Prevention of Recurrent Depression
Giovanni A. Fava, M.D.; Chiara Ruini, Ph.D.; Chiara Rafanelli, M.D., Ph.D.; Livio Finos, Ph.D.; Sandra Conti, M.D.; Silvana Grandi, M.D.
Relationship of Variability in Residual Symptoms With Recurrence of Major Depressive Disorder During Maintenance Treatment
Jordan F. Karp, M.D.; Daniel J. Buysse, M.D.; Patricia R. Houck, M.S.H.; Christine Cherry, M.S.; David J. Kupfer, M.D.; Ellen Frank, Ph.D.
Effects of Major Depression on Moment-in-Time Work Performance
Philip S. Wang, M.D., Dr.P.H.; Arne L. Beck, Ph.D.; Pat Berglund, M.B.A.; David K. McKenas, M.D., M.P.H.; Nicolaas P. Pronk, Ph.D.; Gregory E. Simon, M.D., M.P.H.; Ronald C. Kessler, Ph.D.
Treatment Outcome and Physician-Patient Communication in Primary Care Patients With Chronic, Recurrent Depression
Thomas L. Schwenk, M.D.; Dwight L. Evans, M.D.; Sally K. Laden, M.S.; Lydia Lewis, B.S.
Phenomenology of Rapid-Cycling Bipolar Disorder: Data From the First 500 Participants in the Systematic Treatment Enhancement Program
Christopher D. Schneck, M.D.; David J. Miklowitz, Ph.D.; Joseph R. Calabrese, M.D.; Michael H. Allen, M.D.; Marshall R. Thomas, M.D.; Stephen R. Wisniewski, Ph.D.; Sachiko Miyahara, M.S.; Melvin D. Shelton, M.D., Ph.D.; Terence A. Ketter, M.D.; Joseph F. Goldberg, M.D.; Charles L. Bowden, M.D.; Gary S. Sachs, M.D.
Brief Report
Actors’ Portrayals of Depression to Test Interrater Reliability in Clinical Trials
Jules Rosen, M.D.; Benoit H. Mulsant, M.D.; Martha L. Bruce, Ph.D.; Vikas Mittal, Ph.D.; Debra Fox, M.A.
Using a Self-Report Depression Scale to Identify Remission in Depressed Outpatients
Mark Zimmerman, M.D.; Michael A. Posternak, M.D.; Iwona Chelminski, Ph.D.
Neuropsychological Processing Associated With Recovery From Depression After Stereotactic Subcaudate Tractotomy
Tim Dalgleish, Ph.D.; Jenny Yiend, Ph.D.; Jessica Bramham, B.A.; John D. Teasdale, Ph.D.; Alan D. Ogilvie, M.B.Ch.B.; Gin Malhi, M.B.Ch.B.; Robert Howard, M.D.
Comparison of Cortical 5-HT2A Receptor Binding in Bulimia Nervosa Patients and Healthy Volunteers
Ingeborg Goethals, M.D.; Myriam Vervaet, Ph.D.; Kurt Audenaert, M.D., Ph.D.; Christophe Van de Wiele, M.D., Ph.D.; Hamphrey Ham, M.D., Ph.D.; Marleen Vandecapelle, M.Sc.; Guido Slegers, Pharm.Dr.Sc., Ph.D.; Rudi Dierckx, M.D., Ph.D.; Cees van Heeringen, M.D., Ph.D.
Volumetric Neural Correlates of Antisaccade Eye Movements in First-Episode Psychosis
Ulrich Ettinger, Ph.D.; Veena Kumari, Ph.D.; Xavier A. Chitnis, M.Sc.; Philip J. Corr, Ph.D.; Trevor J. Crawford, Ph.D.; Dominic G. Fannon, M.R.C.Psych.; Séamus O’Ceallaigh, M.R.C.Psych.; Alex L. Sumich, M.A.; Victor C. Doku, M.R.C.Psych.; Tonmoy Sharma, M.R.C.Psych.
Omega-3 Fatty Acid Treatment and T2 Whole Brain Relaxation Times in Bipolar Disorder
Fuyuki Hirashima, B.A.; Aimee M. Parow, B.S.; Andrew L. Stoll, M.D.; Christina M. Demopulos, M.D.; Karen E. Damico, B.A.; Michael L. Rohan, M.S.; Justin G. Eskesen, B.A.; Chun S. Zuo, Ph.D.; Bruce M. Cohen, M.D., Ph.D.; Perry F. Renshaw, M.D., Ph.D.
Letter to the Editor
Clozapine and Typical Antipsychotics
DAVID E. ROSS, M.D.
Prolactin Elevation With Ziprasidone
SHARI I. LUSSKIN, M.D.; ROBERT CANCRO, M.D.; LINDA CHUANG, M.D.; JESSICA JACOBSON
Aripiprazole for Acute Bipolar Mania
KARUPPIAH JAGADHEESAN, M.B.B.S., M.D.; DAVID MUIRHEAD, M.B.B.S., F.R.A.N.Z.C.P.
Schizophrenia, Syndrome X, and Omega-3 Fatty Acids
FRANÇOIS POUWER, Ph.D.; RITSAERT LIEVERSE, M.D., M.Sc.; MICHAELA DIAMANT, M.D., Ph.D.; JOHANNA ASSIES, M.D., Ph.D.
Dr. Lanius Replies
RUTH A. LANIUS, M.D., Ph.D.
The Nature of Traumatic Memories
HARRISON G. POPE, Jr., M.D.
Typical Versus Atypical Antipsychotics
DANIEL LUCHINS, M.D.
Evidence-Based Promotion
JEFFREY A. MATTES, M.D.
Dr. Bauer Replies
MARK S. BAUER, M.D.
Book Forum: Substantial Professional Issues
Research Training in Psychiatry Residency: Strategies for Reform
LEON EISENBERG, M.D.
Advancing DSM: Dilemmas in Psychiatric Diagnosis
ROGER PEELE, M.D.
Book Forum: Nature Versus Nurture
Nature Via Nurture: Genes, Experience, and What Makes Us Human
T. J. CROW, M.D.
The Development of Psychopathology: Nature and Nurture
JAMES R. MERIKANGAS, M.D.
Book Forum: Ethics and Forensics
Life and Death Decisions: Psychological and Ethical Considerations in End-of-Life Care
JACK C. SCHOENHOLTZ, M.D.
Concise Guide to Ethics in Mental Health Care
JEREMY A. LAZARUS, M.D.
Book Forum: Mind, Brain, and Imagination
The Midnight Disease: The Drive to Write, Writer’s Block, and the Creative Brain
DAVID L. NATHAN, M.D.
Imagination and the Meaningful Brain
JOHANNES PANTEL, M.D., Ph.D.
Images In Neuroscience
GABA Neurons in the Human Prefrontal Cortex
Takanori Hashimoto, M.D., Ph.D.; David W. Volk, M.D., Ph.D.; David A. Lewis, M.D.
Images in Psychiatry
Konrad Lorenz, 1903–1989
Francine M. Benes, M.D., Ph.D.
Introspections
The Grand Inquisitor
Richard G. Druss, M.D.
Correction
Correction
APA Official Actions
Highlights of the Annual Meeting
Presidential Paper
Presidential Address
Marcia Kraft Goin, M.D.
Response to the Presidential Address
Michelle B. Riba, M.D., M.S.
Marcia Kraft Goin, M.D., 130th President, 2003–2004
George M. Simpson, M.D.
  |  
Copyright ©
American
Psychiatric
Association